AIMS: A few case series in adults have described the characteristics of epithelioid glioblastoma (e-GB), one of the rarest variants of this cancer. We evaluated clinical, radiological, histological and molecular characteristics in the largest series to date of paediatric e-GB. METHODS: Review of clinical characteristics and therapy, imaging studies and histology was performed in patients younger than 22 years with e-GB seen at our institution over 15 years. Sequencing of hotspot mutations and fluorescence in situ hybridization of relevant genes were undertaken. RESULTS: Median age at diagnosis of six patients was 7.6 years. Tumours originated in the cerebral cortex (n = 2) or diencephalon (n = 4). Three patients presented with acute, massive haemorrhage and three had leptomeningeal dissemination at diagnosis. Paediatric e-GB had the typical histological characteristics seen in adult tumours. Universal immunoreactivity for INI1 and lack of diverse protein expression were seen in all cases. One tumour had a chromosome 22q loss. Three tumours (50%) harboured a BRAF: p.V600E. One thalamic tumour had an H3F3A p.K27M. All patients received radiation therapy with (n = 3) or without chemotherapy (n = 3). All patients experienced tumour progression with a median survival of 169 days. One patient with nonmetastatic disease had early leptomeningeal progression. Two patients had symptomatic tumour spread outside the central nervous system (CNS) through a ventriculoperitoneal shunt. One additional patient had widespread metastases outside the CNS identified at autopsy. CONCLUSIONS: Paediatric e-GBs are rare cancers with an aggressive behaviour that share histological and genetic characteristics with their adult counterparts. BRAF inhibition is a potential treatment for these tumours.
AIMS: A few case series in adults have described the characteristics of epithelioid glioblastoma (e-GB), one of the rarest variants of this cancer. We evaluated clinical, radiological, histological and molecular characteristics in the largest series to date of paediatric e-GB. METHODS: Review of clinical characteristics and therapy, imaging studies and histology was performed in patients younger than 22 years with e-GB seen at our institution over 15 years. Sequencing of hotspot mutations and fluorescence in situ hybridization of relevant genes were undertaken. RESULTS: Median age at diagnosis of six patients was 7.6 years. Tumours originated in the cerebral cortex (n = 2) or diencephalon (n = 4). Three patients presented with acute, massive haemorrhage and three had leptomeningeal dissemination at diagnosis. Paediatric e-GB had the typical histological characteristics seen in adult tumours. Universal immunoreactivity for INI1 and lack of diverse protein expression were seen in all cases. One tumour had a chromosome 22q loss. Three tumours (50%) harboured a BRAF: p.V600E. One thalamic tumour had an H3F3Ap.K27M. All patients received radiation therapy with (n = 3) or without chemotherapy (n = 3). All patients experienced tumour progression with a median survival of 169 days. One patient with nonmetastatic disease had early leptomeningeal progression. Two patients had symptomatic tumour spread outside the central nervous system (CNS) through a ventriculoperitoneal shunt. One additional patient had widespread metastases outside the CNS identified at autopsy. CONCLUSIONS: Paediatric e-GBs are rare cancers with an aggressive behaviour that share histological and genetic characteristics with their adult counterparts. BRAF inhibition is a potential treatment for these tumours.
Authors: J A Kraus; K Lamszus; N Glesmann; M Beck; M Wolter; M Sabel; D Krex; T Klockgether; G Reifenberger; U Schlegel Journal: Acta Neuropathol Date: 2001-04 Impact factor: 17.088
Authors: J Wyatt-Ashmead; B K Kleinschmidt-DeMasters; D A Hill; G W Mierau; L McGavran; S J Thompson; N K Foreman Journal: Clin Neuropathol Date: 2001 Nov-Dec Impact factor: 1.368
Authors: Daniel J Brat; Bernd W Scheithauer; Rafael Medina-Flores; Marc K Rosenblum; Peter C Burger Journal: Am J Surg Pathol Date: 2002-06 Impact factor: 6.394
Authors: Ranjith Babu; Jeffrey Hatef; Roger E McLendon; Thomas J Cummings; John H Sampson; Allan H Friedman; Cory Adamson Journal: J Neurosurg Date: 2013-05-03 Impact factor: 5.115
Authors: David A Solomon; Matthew D Wood; Tarik Tihan; Andrew W Bollen; Nalin Gupta; Joanna J J Phillips; Arie Perry Journal: Brain Pathol Date: 2015-12-14 Impact factor: 6.508
Authors: Alberto Broniscer; Sujuan Jia; Belinda Mandrell; Dima Hamideh; Jie Huang; Arzu Onar-Thomas; Amar Gajjar; Susana C Raimondi; Ruth G Tatevossian; Clinton F Stewart Journal: Pediatr Blood Cancer Date: 2018-03-07 Impact factor: 3.167
Authors: Michael Zhang; Richard Li; Erqi L Pollom; Arya Amini; Savita Dandapani; Gordon Li Journal: J Clin Neurosci Date: 2020-11-06 Impact factor: 1.961